ANL — Adlai Nortye Ltd. stock price, charts and financials

QT83Adlai Nortye Ltd.

Adlai Nortye Ltd. (NASDAQ: ANL) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
15.74
+0.46+3.01%
OverviewShort InterestFilings
ANLQT83Adlai Nortye Ltd.·NASDAQ
15.74+3.01%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 15, 2026EFFECTNotice of effectiveness
Sep 11, 2026S-8 POSS-8 POS
Sep 11, 2026S-8 POSS-8 POS
Sep 11, 2026POS AMPost-effective amendment
Sep 08, 20266-KForeign issuer report
Aug 26, 20266-KForeign issuer report
Aug 26, 20264Statement of changes in beneficial ownership
Aug 19, 20266-KForeign issuer report
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 20266-KForeign issuer report
Aug 04, 20263Initial statement of beneficial ownership
Aug 03, 20266-KForeign issuer report
Jul 20, 2026424B7424B7
Jul 17, 20266-KForeign issuer report
Jul 15, 20263Initial statement of beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 01, 20263Initial statement of beneficial ownership
May 28, 20263Initial statement of beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 21, 20263Initial statement of beneficial ownership
May 20, 20263Initial statement of beneficial ownership
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 20263/AInitial statement of beneficial ownership (amended)
#1 / 25 of 101
Page
▼
/ 5